Clinical Trials
2 trialsNCT05236257 2024-12-10
EPI VITRAKVI
Bayer
Completed
NCT05192642 2023-11-14
A Study Called VICTORIA to Learn More About How Well Larotrectinib Works in Adults With TRK Fusion-positive Cancer by Comparing Larotrectinib Data From Clinical Studies With Data of Other Treatments From Actual Practice
Bayer
Completed